CIA
TMO icon

Concurrent Investment Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Concurrent Investment Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$11.4M Buy
22,699
+13,232
+140% +$6.35M 0.1% 229
2026
Q1 		$4.65M Sell
9,467
-1,136
-11% -$617K 0.05% 370
2025
Q4 		$6.14M Buy
10,603
+6,020
+131% +$3.4M 0.07% 281
2025
Q3 		$2.22M Buy
4,583
+13
+0.3% +$6.05K 0.04% 433
2025
Q2 		$1.85M Buy
4,570
+748
+20% +$313K 0.04% 453
2025
Q1 		$1.9M Buy
3,822
+382
+11% +$207K 0.05% 374
2024
Q4 		$1.79M Sell
3,440
-147
-4% -$80.8K 0.05% 352
2024
Q3 		$2.22M Buy
3,587
+179
+5% +$106K 0.07% 285
2024
Q2 		$1.88M Buy
3,408
+1,315
+63% +$753K 0.06% 290
2024
Q1 		$1.22M Buy
2,093
+176
+9% +$98.8K 0.05% 341
2023
Q4 		$1.02M Buy
+1,917
New +$928K 0.05% 336

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Concurrent Investment Advisors's TMO Position: Q2 2026 in Review

Concurrent Investment Advisors increased its Thermo Fisher Scientific (TMO) stake by 140% in Q2 2026, buying an estimated $6.35M and bringing the position to 22,699 shares worth $11.4M. The position accounts for 0.1% of the portfolio, ranked #229.

Concurrent Investment Advisors first reported a position in TMO in Q4 2023 and has held it in 11 quarters since. 2,630 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Concurrent Investment Advisors held 22,699 shares of Thermo Fisher Scientific worth $11.4M as of Q2 2026.
  • Concurrent Investment Advisors bought 13,232 Thermo Fisher Scientific shares in Q2 2026, an estimated $6.35M.
  • Thermo Fisher Scientific made up 0.1% of Concurrent Investment Advisors's portfolio in Q2 2026, its #229 holding.
  • Concurrent Investment Advisors first reported a position in Thermo Fisher Scientific in Q4 2023 and has held it in 11 quarters since.
  • 2,630 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Concurrent Investment Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.